Skip to content

Human clinical Trial for the efficacy of AUL NiacinGold™ Sun Screen in UV protection long-lasting effect for 24 hours after one use

Human clinical Trial for the efficacy of AUL NiacinGold™ Sun Screen in UV protection long-lasting effect for 24 hours after one use

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0012183
Enrollment
22
Registered
2026-06-26
Start date
2025-02-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(AUL NiacinGold™ Sun Screen) : In this test, the test product (AUL Niacin Gold Sunscreen) was applied once to the volar forearm of the test subject on the test day.

Sponsors

Human Co., Ltd. Skin Clinical Trial Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: - Healthy Korean female adults over the age of 19 - Subjects who have signed a consent form voluntarily after being informed sufficiently on the objectives of study and all related contents - Subjects who are healthy without acute and chronic diseases including skin disorders - Subjects who can be observed and traced throughout the entire study period

Exclusion criteria

Exclusion criteria: - Subjects who are pregnant, breastfeeding, or planning a pregnancy - Subjects who have psychiatric disease and infectious skin disease - Subjects who have used an ointment containing steroids for more than 1 month - Subjects who participated in the similar test within the past 6 months - Subjects who have sensitive and hypersensitive skin - Subjects who have abnormal skin findings at the test site, including moles, acne, erythema, or telangiectasia. - Subjects who have used cosmetics or drugs on the test site with same efficacy within the past 3 months - Subjects who have undergone dermatological treatment or procedures (e.g., liposuction, laser treatment, ultrasound lipolysis, or other skin care procedures) on the test site within the past 6 months - Subjects who are employees of the Sponsor - Subjects deemed by the principal investigator to be unsuitable for participation in the study.

Design outcomes

Primary

MeasureTime frame
Evaluation of long-lasting UV protection effect

Secondary

MeasureTime frame
Efficacy self report questionnaire;Assessment of skin Adverse Event(AE)

Countries

Korea, Republic of

Contacts

Public ContactKim Su Yeoung

Human Co., Ltd. Skin Clinical Trial Center

ksy1@humantest.co.kr+82-70-8664-1074

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Jul 3, 2026